Hikma Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,349	3,127	2,875	2,517	2,553
Revenue Growth	7.10%	8.77%	14.22%	-1.41%	9.06%
Cost of Revenue	1,908	1,712	1,485	1,279	1,252
Gross Profit	1,441	1,415	1,390	1,238	1,301
Selling, General & Admin	743	671	767	615	561
Research & Development	151	141	149	144	143
Other Operating Expenses	5	-9	107	197	15
Total Operating Expenses	899	803	1,023	956	719
Operating Income	542	612	367	282	582
Interest Income	83	9	7	29	31
Interest Expense	-107	-167	-95	-81	-69
Other Non-Operating Income (Expense)	1	1	2	3	-
Total Non-Operating Income (Expense)	-23	-157	-86	-49	-38
Pretax Income	519	455	281	233	544
Provision for Income Taxes	112	93	89	42	124
Net Income	407	362	192	191	420
Minority Interest in Earnings	5	3	2	3	-1
Net Income to Common	402	359	190	188	421
Net Income Growth	11.98%	88.95%	1.06%	-55.34%	-2.32%
Shares Outstanding (Basic)	221	221	221	224	231
Shares Outstanding (Diluted)	223	223	222	225	233
Shares Change	-0.36%	0.51%	-1.13%	-3.47%	-2.10%
EPS (Basic)	1.82	1.62	0.86	0.84	1.82
EPS (Diluted)	1.81	1.61	0.85	0.84	1.81
EPS Growth	12.42%	89.41%	1.19%	-53.51%	-0.22%

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	239	399	439	392	493
Free Cash Flow Growth	-40.10%	-9.11%	11.99%	-20.49%	68.84%
Free Cash Flow Per Share	1.07	1.79	1.97	1.74	2.12
Dividends Per Share	0.840	0.800	0.720	0.560	0.540
Dividend Growth	5.00%	11.11%	28.57%	3.70%	8.00%
Gross Margin	43.03%	45.25%	48.35%	49.19%	50.96%
Operating Margin	16.18%	19.57%	12.77%	11.20%	22.80%
Profit Margin	12.15%	11.58%	6.68%	7.59%	16.45%
FCF Margin	7.14%	12.76%	15.27%	15.57%	19.31%
EBITDA	780	780	626	654	727
EBITDA Margin	23.29%	24.94%	21.77%	25.98%	28.48%
EBIT	542	612	367	282	582
EBIT Margin	16.18%	19.57%	12.77%	11.20%	22.80%
Effective Tax Rate	21.58%	20.44%	31.67%	18.03%	22.79%